The AstraZeneca PLC ADR AZN slipped 0.55% to $65.37 Tuesday, on what proved to be an all-around mixed trading session for the ...

NDAQ:AZN) AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information ...

AstraZeneca PLC (AZN) stock saw a decline, ending the day at $65.73 which represents a decrease of $-1.28 or -1.91% from the prior close of $67.01. The stock opened at $65.88 and touched a low of $65.

We recently published a list of Billionaire George Soros Stock Portfolio: Top 10 Stock Picks. In this article, we are going ...

This latest approval for Orpathys in NSCLC makes the drug available in both the first- and second-line settings.

Shares of AstraZeneca PLC AZN slipped 1.77% to £106.30 Tuesday, on what proved to be an all-around poor trading session for ...

This writer currently owns 14 different FTSE 100 shares in his portfolio. Here's a quick look at what they are and why he ...

A list of pharmaceutical representatives at the table when the Biden administration negotiated Medicare drug prices reveals ...

The FDA's priority review status recognised "the potential for datopotamab deruxtecan to provide a much-needed option to patients whose disease has become resistant to current treatments," added Susan ...

If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...

AstraZeneca PLC (AZN) stock saw a modest uptick, ending the day at $67.01 which represents a slight increase of $0.43 or 0.65% from the prior close of $66.58. The stock opened at $67.19 and touched a ...

SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...